These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21861150)
21. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status. Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576 [TBL] [Abstract][Full Text] [Related]
22. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype. Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730 [TBL] [Abstract][Full Text] [Related]
23. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group. Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182 [TBL] [Abstract][Full Text] [Related]
24. [Improved prognostic assessment of head-neck carcinomas by new genetic markers]. Bockmühl U; Küchler I; Petersen I HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226 [TBL] [Abstract][Full Text] [Related]
25. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR; Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175 [TBL] [Abstract][Full Text] [Related]
26. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331 [TBL] [Abstract][Full Text] [Related]
27. [Translational approaches in cancer stem cell research]. Mozet C; Wichmann G; Dietz A HNO; 2011 Sep; 59(9):859-65. PubMed ID: 21847639 [TBL] [Abstract][Full Text] [Related]
28. Histopathologic findings of HPV and p16 positive HNSCC. Mendelsohn AH; Lai CK; Shintaku IP; Elashoff DA; Dubinett SM; Abemayor E; St John MA Laryngoscope; 2010 Sep; 120(9):1788-94. PubMed ID: 20803740 [TBL] [Abstract][Full Text] [Related]
29. Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer. Zhao N; Ang MK; Yin XY; Patel MR; Fritchie K; Thorne L; Muldrew KL; Hayward MC; Sun W; Wilkerson MD; Chera BS; Hackman T; Zanation AM; Grilley-Olson JE; Couch ME; Shockley WW; Weissler MC; Shores CG; Funkhouser WK; Olshan AF; Hayes DN Br J Cancer; 2012 Jul; 107(3):482-90. PubMed ID: 22735904 [TBL] [Abstract][Full Text] [Related]
31. NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy. Ramesh PS; Devegowda D; Singh A; Thimmulappa RK Crit Rev Oncol Hematol; 2020 Apr; 148():102885. PubMed ID: 32062315 [TBL] [Abstract][Full Text] [Related]
32. The role of MAGEA2 in head and neck cancer. Glazer CA; Smith IM; Bhan S; Sun W; Chang SS; Pattani KM; Westra W; Khan Z; Califano JA Arch Otolaryngol Head Neck Surg; 2011 Mar; 137(3):286-93. PubMed ID: 21422315 [TBL] [Abstract][Full Text] [Related]
33. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer]. Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma. Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895 [TBL] [Abstract][Full Text] [Related]
35. Current potential and limitations of molecular diagnostic methods in head and neck cancer. Mahfouz ME; Rodrigo JP; Takes RP; Elsheikh MN; Rinaldo A; Brakenhoff RH; Ferlito A Eur Arch Otorhinolaryngol; 2010 Jun; 267(6):851-60. PubMed ID: 20037788 [TBL] [Abstract][Full Text] [Related]
36. Significance of DE Jesus Oliveira Kato V; DE Abreu MC; DE Brito Kato AM; DE Souza LL; Pontes FSC; DE Castro Sant'anna C; GonÇalves A; Pontes HAR; Khayat AS; Burbano RMR Anticancer Res; 2020 Nov; 40(11):6355-6366. PubMed ID: 33109573 [TBL] [Abstract][Full Text] [Related]
37. Assessment and clinicopathological correlation of p16 expression in head and neck squamous cell carcinoma. Ralli M; Singh S; Yadav SP; Sharma N; Verma R; Sen R J Cancer Res Ther; 2016; 12(1):232-7. PubMed ID: 27072243 [TBL] [Abstract][Full Text] [Related]
38. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation. Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684 [TBL] [Abstract][Full Text] [Related]
39. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up]. Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570 [TBL] [Abstract][Full Text] [Related]
40. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer. Dreyer JH; Hauck F; Barros MHM; Niedobitek G Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]